Tag: AnteoTech
European EV manufacturer places first commercial order for AnteoTech’s Ultranode
AnteoTech has received its first commercial order for its Ultranode battery anode technology, valued at AUD 40,000, from leading European electric vehicle manufacturer EV1 as part of its battery optimisation program.
AnteoTech inks EuGeni distribution agreement for Greece and Cyprus
Queensland biotechnology company AnteoTech has signed a distribution agreement with Ramma Dental SA for the distribution of its EuGeni Reader and accompanying COVID-19 Antigen...
AnteoTech inks Philippines distribution agreement for EuGeni
Brisbane company AnteoTech has signed a distribution agreement with UC Biosciences Inc. (Unison) for the distribution of the EuGeni Reader platform and Covid-19 Antigen...
AnteoTech signs UK distribution agreement with Apacor Limited
Queensland-based biotechnology company AnteoTech has signed a distribution agreement with Apacor Limited for the distribution of the EuGeni Reader and accompanying COVID-19 Antigen Rapid...
AnteoTech inks first multi-territory EuGeni distribution agreement with Biomed Global
Queensland-based biotechnology company AnteoTech has signed a distribution agreement with Biomed Global and its subsidiaries for the distribution of its EuGeni Reader and accompanying...
Palaszczuk Government launches $1.84 billion jobs fund
Media Release
The Palaszczuk Government has launched a new flagship program, bringing together $1.84 billion in measures designed to turbo-charge job creation in Queensland.
Premier Annastacia...
AnteoTech officially launches 15-minute rapid COVID-19 test
Media Release
Queensland company AnteoTech has officially launched its 15-minute COVID-19 antigen rapid test (ART) platform, EuGeni.
Deputy-Premier and Minister for State Development Steven Miles joined...
AnteoTech’s 15-min rapid Covid-19 test wins European tick of approval
Life science and nano-scale surface chemistry company, AnteoTech, has won a crucial European accreditation for its innovative point-of-care COVID-19 antigen rapid test platform, EuGeni.
AnteoTech...
Brisbane company to accelerate development of rapid COVID-19 test
Media Release
Brisbane company AnteoTech is one step closer to delivering an innovative point-of-care (PoC) rapid COVID-19 test thanks to vital funding from the Palaszczuk...
Featured Article
Embracing the future: Australian manufacturing trends in 2025
As the calendar turns to 2025, the Australian manufacturing sector stands at the cusp of transformation.
